Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism

Hypertension

Volumn 65, Issue 5, 2015, Pages 1096-1102

  Satoh, Fumitoshi ^a   Morimoto, Ryo ^a   Ono, Yoshikiyo ^a   Iwakura, Yoshitsugu ^a   Omata, Kei ^a   Kudo, Masataka ^a   Takase, Kei ^a   Seiji, Kazumasa ^a   Sasamoto, Hidehiko ^a   Honma, Seijiro ^b   Okuyama, Mitsunobu ^b   Yamashita, Kouwa ^c   Gomez Sanchez, Celso E ^d   Rainey, William E ^e   Arai, Yoichi ^a   Sasano, Hironobu ^b   Nakamura, Yasuhiro ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b Grelan Pharmaceutical Co   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

1 (2 (18F)fluoro 3 pyridyl) 4 (2 isopropyl 1 oxo isoindoline 5 yl) 5 methyl 1H 1 2 3 triazole; hyperaldosteronism

Indexed keywords

18 HYDROXYHYDROCORTISONE; 18 OXOHYDROCORTISONE; ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DEXAMETHASONE; HYDROCORTISONE; POTASSIUM; RENIN; SODIUM; 18-HYDROXYCORTISOL; 18-OXOCORTISOL; BIOLOGICAL MARKER;

ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONOMA; ARTICLE; BILATERAL HYPERALDOSTERONISM; BLOOD ANALYSIS; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DISPLAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; ADRENAL GLAND NEOPLASMS; ANALOGS AND DERIVATIVES; BLOOD; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HYPERALDOSTERONISM; MASS FRAGMENTOGRAPHY; MIDDLE AGED; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADENOMA; ADRENAL GLAND NEOPLASMS; ALDOSTERONE; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937431891     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04453     Document Type: Article

References (33)

1. Stowasser M, Gordon RD. Primary aldosteronism-careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004; 217: 33-39. doi: 10.1016/j.mce.2003.10.006
2. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr. WF Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004; 89: 1045-1050. doi: 10.1210/jc.2003-031337
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005; 45: 1243-1248. doi: 10.1016/j. jacc.2005.01.015
4. Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled crosssectional study. Hypertension. 2013; 62: 331-336. doi: 10.1161/HYPERTENSIONAHA.113.01060
5. Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, Arai Y, Nakamura Y, Sasano H, Ito S, Satoh F. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab. 2014; 99: 1593-1598. doi: 10.1210/jc.2013-2180
6. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008; 93: 3266-3281. doi: 10.1210/jc.2008-0104
7. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A; Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009. Endocr J. 2011; 58: 711-721
8. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, Van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004; 136: 1227-1235. doi: 10.1016/j.surg.2004.06.051
9. Satoh F, Abe T, Tanemoto M, Nakamura M, Abe M, Uruno A, Morimoto R, Sato A, Takase K, Ishidoya S, Arai Y, Suzuki T, Sasano H, Ishibashi T, Ito S. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res. 2007; 30: 1083-1095. doi: 10.1291/hypres.30.1083
10. Rossi GP, Barisa M, Allolio B, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012; 97: 1606-1614. doi: 10.1210/jc.2011-2830
11. Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, Satoh F, Young Jr. WF An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014; 63: 151-160. doi: 10.1161/HYPERTENSIONAHA.113.02097
12. Kempers MJ, Lenders JW, Van Outheusden L, Van Der Wilt GJ, Schultze Kool LJ, Hermus AR, Deinum J. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009; 151: 329-337
13. Ulick S, Blumenfeld JD, Atlas SA, Wang JZ, Vaughan Jr. ED The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 1993; 76: 873-878. doi: 10.1210/jcem.76.4.8473399
14. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab. 1998; 83: 3996-4001. doi: 10.1210/jcem.83.11.5237
15. Freel EM, Shakerdi LA, Friel EC, Wallace AM, Davies E, Fraser R, Connell JM. Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects. J Clin Endocrinol Metab. 2004; 89: 4628-4633. doi: 10.1210/jc.2004-0379
16. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid- remediable aldosteronism and human hypertension. Nature. 1992; 355: 262-265. doi: 10.1038/355262a0
17. Stowasser M, Bachmann AW, Tunny TJ, Gordon RD. Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol. 1996; 23: 591-593
18. Reynolds RM, Shakerdi LA, Sandhu K, Wallace AM, Wood PJ, Walker BR. The utility of three different methods for measuring urinary 18-hydroxycortisol in the differential diagnosis of suspected primary hyperaldosteronism. Eur J Endocrinol. 2005; 152: 903-907. doi: 10.1530/eje.1.01922
19. Mosso L, Gómez-Sánchez CE, Foecking MF, Fardella C. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension. 2001; 38(3 pt 2): 688-691
20. Mulatero P, di Cella S, Monticone S, Schiavone D, Manzo M, Mengozzi G, Rabbia F, Terzolo M, Gomez-Sanchez EP, Gomez-Sanchez CE, Veglio F. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab. 2012; 97: 881-889. doi: 10.1210/jc.2011-2384
21. Nakamura Y, Satoh F, Morimoto R, Kudo M, Takase K, Gomez-Sanchez CE, Honma S, Okuyama M, Yamashita K, Rainey WE, Sasano H, Ito S. 18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab. 2011; 96: E1272-E1278. doi: 10.1210/jc.2010-2785
22. Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, Izumiyama H, Sasano H, Hirata Y. Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome. Endocr J. 2011; 58: 543-551
23. Fallo F, Bertello C, Tizzani D, Fassina A, Boulkroun S, Sonino N, Monticone S, Viola A, Veglio F, Mulatero P. Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J Hypertens. 2011; 29(9): 1773-1777. doi: 10.1097/HJH.0b013e32834937f3
24. Yamashita K, Okuyama M, Nakagawa R, Honma S, Satoh F, Morimoto R, Ito S, Takahashi M, Numazawa M. Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids. J Chromatogr A. 2008; 1200(2): 114-121. doi: 10.1016/j.chroma.2008.05.034
25. Sasano H, Mason JI, Sasano N, Nagura H. Immunolocalization of 3β-hydroxysteroid dehydrogenase in human adrenal cortex and in its disorders. Endocr Pathol. 1990; 1: 94-101
26. Doi M, Satoh F, Maekawa T, Nakamura Y, Fustin JM, Tainaka M, Hotta Y, Takahashi Y, Morimoto R, Takase K, Ito S, Sasano H, Okamura H. Isoform-specific monoclonal antibodies against 3β-hydroxysteroid dehydrogenase/isomerase family provide markers for subclassification of human primary aldosteronism. J Clin Endocrinol Metab. 2014; 99: E257-E262. doi: 10.1210/jc.2013-3279
27. Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez- Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 2014; 383: 111-117. doi: 10.1016/j.mce.2013.11.022
28. Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill Jr Jr. JR Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab. 2000; 85: 4526-4533. doi: 10.1210/jcem.85.12.7086
29. Matsuura T, Takase K, Ota H, Yamada T, Sato A, Satoh F, Takahashi S. Radiologic anatomy of the right adrenal vein: preliminary experience with MDCT. AJR Am J Roentgenol. 2008; 191: 402-408. doi: 10.2214/AJR.07.3338
30. Ishidoya S, Kaiho Y, Ito A, Morimoto R, Satoh F, Ito S, Ishibashi T, Nakamura Y, Sasano H, Arai Y. Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling. Urology. 2011; 78: 68-73. doi: 10.1016/j.urology.2010.12.042
31. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006; 29: 883-889. doi: 10.1291/hypres.29.883
32. Ono Y, Nakamura Y, Maekawa T, Felizola SJ, Morimoto R, Iwakura Y, Kudo M, Seiji K, Takase K, Arai Y, Gomez-Sanchez CE, Ito S, Sasano H, Satoh F. Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas. Hypertension. 2014; 64: 438-444. doi: 10.1161/HYPERTENSIONAHA.113.02944
33. Monticone S, Satoh F, Giacchetti G, Viola A, Morimoto R, Kudo M, Iwakura Y, Ono Y, Turchi F, Paci E, Veglio F, Boscaro M, Rainey W, Ito S, Mulatero P. Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. Hypertension. 2012; 59: 840-846. doi: 10.1161/HYPERTENSIONAHA.111.189548